1. Home
  2. GPMT vs GALT Comparison

GPMT vs GALT Comparison

Compare GPMT & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • GALT
  • Stock Information
  • Founded
  • GPMT 2015
  • GALT 2000
  • Country
  • GPMT United States
  • GALT United States
  • Employees
  • GPMT N/A
  • GALT N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • GALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPMT Real Estate
  • GALT Health Care
  • Exchange
  • GPMT Nasdaq
  • GALT Nasdaq
  • Market Cap
  • GPMT 95.4M
  • GALT 83.5M
  • IPO Year
  • GPMT 2017
  • GALT N/A
  • Fundamental
  • Price
  • GPMT $2.58
  • GALT $1.35
  • Analyst Decision
  • GPMT Buy
  • GALT Hold
  • Analyst Count
  • GPMT 3
  • GALT 1
  • Target Price
  • GPMT $2.75
  • GALT N/A
  • AVG Volume (30 Days)
  • GPMT 393.5K
  • GALT 176.3K
  • Earning Date
  • GPMT 05-06-2025
  • GALT 05-15-2025
  • Dividend Yield
  • GPMT 7.72%
  • GALT N/A
  • EPS Growth
  • GPMT N/A
  • GALT N/A
  • EPS
  • GPMT N/A
  • GALT N/A
  • Revenue
  • GPMT N/A
  • GALT N/A
  • Revenue This Year
  • GPMT N/A
  • GALT N/A
  • Revenue Next Year
  • GPMT $34.16
  • GALT N/A
  • P/E Ratio
  • GPMT N/A
  • GALT N/A
  • Revenue Growth
  • GPMT N/A
  • GALT N/A
  • 52 Week Low
  • GPMT $1.61
  • GALT $0.73
  • 52 Week High
  • GPMT $3.66
  • GALT $3.17
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 63.74
  • GALT 48.58
  • Support Level
  • GPMT $2.26
  • GALT $1.22
  • Resistance Level
  • GPMT $2.60
  • GALT $1.36
  • Average True Range (ATR)
  • GPMT 0.09
  • GALT 0.09
  • MACD
  • GPMT 0.03
  • GALT 0.00
  • Stochastic Oscillator
  • GPMT 88.06
  • GALT 47.57

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: